Microba Life Sciences Ltd (MAP) — Financial Flexibility Index
Microba Life Sciences Ltd (MAP) has a Financial Flexibility Index of -0.45x as of December 2025. Free cash flow of AU$-5.51 Million (operating CF AU$-5.70 Million minus capex AU$189.71K) represents 0% of total liabilities (AU$12.27 Million). Also explore Microba Life Sciences Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Microba Life Sciences Ltd Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Microba Life Sciences Ltd across 7 annual periods. Check Microba Life Sciences Ltd (MAP) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Microba Life Sciences Ltd (2018–2024)
Year-by-year free cash flow to debt coverage for Microba Life Sciences Ltd. For the full company profile including market capitalisation, see market value of Microba Life Sciences Ltd.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.61x | AU$-9.11 Million | AU$-12.01 Million | AU$14.94 Million | ▲ +8.3% |
| 2023 | -0.66x | AU$-11.19 Million | AU$-15.57 Million | AU$16.82 Million | ▲ +41.5% |
| 2022 | -1.14x | AU$-9.36 Million | AU$-12.39 Million | AU$8.23 Million | ▲ +21.2% |
| 2021 | -1.44x | AU$-8.58 Million | AU$-10.45 Million | AU$5.94 Million | ▲ +21.3% |
| 2020 | -1.83x | AU$-6.51 Million | AU$-7.18 Million | AU$3.55 Million | ▼ -64.1% |
| 2019 | -1.12x | AU$-3.47 Million | AU$-4.32 Million | AU$3.10 Million | ▲ +42.5% |
| 2018 | -1.94x | AU$-2.78 Million | AU$-3.62 Million | AU$1.43 Million | — |